Cargando…
Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
BACKGROUND: Abnormal lipid deposition in the progress of diabetic nephropathy (DN) plays an important role in a number of studies that have shown that SGLT2 inhibitor (SGLT2i) empagliflozin plays an important role in lipid metabolism, but its mechanism is still unclear. METHODS: We aimed to explore...
Autores principales: | Zhang, Zhiqin, Ni, Lihua, Zhang, Lian, Zha, Dongqing, Hu, Chun, Zhang, Lingli, Feng, Huiling, Wei, Xiaobao, Wu, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822229/ https://www.ncbi.nlm.nih.gov/pubmed/33500643 http://dx.doi.org/10.2147/DMSO.S289712 |
Ejemplares similares
-
Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
por: Park, Hoon Suk, et al.
Publicado: (2016) -
Erratum to: Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy
por: Park, Hoon Suk, et al.
Publicado: (2016) -
AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice
por: Fang, Qian, et al.
Publicado: (2023) -
AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice
por: Iwabu, Masato, et al.
Publicado: (2021) -
Expression of AdipoR1 and AdipoR2 Receptors as Leptin-Breast Cancer Regulation Mechanisms
por: Mociño-Rodríguez, Martha Daniela, et al.
Publicado: (2017)